GIBTULIO MET 12.5/500MG TABLET is a combination of Empagliflozin and Metformin which belongs to the group of medicines called Antidiabetic agents. GIBTULIO MET 12.5/500MG TABLET is indicated for the management of type II diabetes mellitus in addition to diet and exercise among adults who remain unresponsive to therapy with either metformin alone or in combination with other antidiabetic medicines.   

GIBTULIO MET 12.5/500MG TABLET can also be used in combination with other medicines (including insulin) to achieve better control of blood sugar level. Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin or the produced insulin does not work well. Symptoms include excessive urination, excessive thirst, hunger, fatigue and blurred vision.

Along management with GIBTULIO MET 12.5/500MG TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. Avoid consumption of alcohol during management with GIBTULIO MET 12.5/500MG TABLET as it could aggravate your existing disease condition.    

Management with GIBTULIO MET 12.5/500MG TABLET must be discontinued for a short time, if you have any conditions that may be associated with dehydration (such as vomiting, diarrhea, fever, exposure to heat or less fluid intake). During management with GIBTULIO MET 12.5/500MG TABLET, your doctor will check your kidney function at least once a year or more frequently especially if you are elderly.

For diabetic patients, it is recommended to check their foot regularly and adhere to any other advice regarding foot care given by your doctor. GIBTULIO MET 12.5/500MG TABLET is generally not recommended for use in pregnant or breastfeeding women, including children and adolescents (aged less than 18 years) due to lack of safety data.

The most common side effects of taking GIBTULIO MET 12.5/500MG TABLET are hypoglycemia (low blood glucose), nausea, vomiting, diarrhea, excessive thirst, change in taste or dizziness. Consult your doctor if any of the side effects worsen.